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Abstract
Background: TcSMUG L products were recently identified as novel mucin-type glycoconjugates restricted to the surface of
insect-dwelling epimastigote forms of Trypanosoma cruzi, the etiological agent of Chagas disease. The remarkable
conservation of their predicted mature N-terminal region, which is exposed to the extracellular milieu, suggests that
TcSMUG L products may be involved in structural and/or functional aspects of the interaction with the insect vector.
Methodology and Principal Findings: Here, we investigated the putative roles of TcSMUG L mucins in both in vivo
development and ex vivo attachment of epimastigotes to the luminal surface of the digestive tract of Rhodnius prolixus. Our
results indicate that the exogenous addition of TcSMUG L N-terminal peptide, but not control T. cruzi mucin peptides, to the
infected bloodmeal inhibited the development of parasites in R. prolixus in a dose-dependent manner. Pre-incubation of
insect midguts with the TcSMUG L peptide impaired the ex vivo attachment of epimastigotes to the luminal surface
epithelium, likely by competing out TcSMUG L binding sites on the luminal surface of the posterior midgut, as revealed by
fluorescence microscopy.
Conclusion and Significance: Together, these observations indicate that TcSMUG L mucins are a determinant of both
adhesion of T. cruzi epimastigotes to the posterior midgut epithelial cells of the triatomine, and the infection of the insect
vector, R. prolixus.
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Introduction
Described by its discoverer, Carlos Chagas [1,2], as ‘‘one of the
most injurious tropical illnesses, specially to children in contam-
inated areas, either in determining a chronic sickly condition in
which people become unable to perform vital activities or as an
important factor of human degeneration,’’ Chagas disease remains
a major tropical human disease in much of Latin America,
affecting approximately 11 million people. There are 300,000 new
cases of Chagas disease each year, with approximately 21,000
deaths annually [3]. Various triatomine vectors, including
Rhodnius, Triatoma and Pastrongylus, are able to acquire and transmit
Trypanosoma cruzi, the etiological agent of Chagas disease [4,5].
During their development within insects, parasites undergo
profound morphological changes, modulating surface molecules
to enable interactions with specific insect tissues that are essential
for their survival, development and successful transmission to a
vertebrate host [6,7]. T. cruzi-insect vector interactions begin when
the insect feeds on the blood of an infected vertebrate host. Once
ingested, most of the bloodstream trypomastigotes differentiate
into non-infective epimastigote forms. In the posterior midgut,
they repeatedly divide by binary fission and adhere to perimicro-
villar membranes (PMM) secreted by the underlying midgut
epithelial cells [8–11]. In the rectum, a proportion of epimastigotes
attaches to the rectal cuticle through hydrophobic interactions and
transforms into non-replicative infective metacyclic trypomasti-
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gotes, which are released together with insect feces and urine
during blood feeding [12–14].
The entire surface of T. cruzi is covered in glycosylpho-
sphatidylinositol (GPI)-anchored mucin molecules that determine
parasite protection and establishment of a persistent infection in
vertebrate hosts [15]. T. cruzi mucins comprise a large gene family
that can be split into two major groups, termed T. cruzi mucin gene
family (TcMUC) and T. cruzi small mucin-like gene family
(TcSMUG), based on sequence comparisons [16]. TcMUC codes
for more than 1,000 polymorphic products, which are largely co-
expressed on the surface of the mammal-dwelling stages [16–18].
In addition to their putative immune modulatory role [17,19], one
particular TcMUC product termed TSSA (trypomastigote small
surface antigen) was recently shown to be involved in trypomas-
tigote adhesion to non-macrophagic cells [20]. The second mucin
group, TcSMUG, displays significantly less diversity and codes for
very small open reading frames. Upon processing of the signal
peptide and GPI-anchoring signal, the average predicted molec-
ular mass for the mature apo-mucins would be ,7 kDa, with Thr
representing as much as 50% of the residues. The hydroxyl groups
of some of these Thr residues are further derivatized with short O-
linked oligosaccharide chains in the Golgi/post-Golgi compart-
ments, which increases the molecular mass of the mature mucins
to 35–50 kDa, depending on both the particular TcSMUG product
and the parasite isolate [21,22]. TcSMUG is composed of two
subgroups of genes, named L and S, which display .80% identity
on average. Mass spectrometry analyses identified TcSMUG S
products as the backbone for the 35/50 kDa mucins (known as
Gp35/50 mucins) expressed on the surface of insect-dwelling
stages [22]. Upon transmission to the mammalian host, Gp35/50
mucins on the surface of metacyclic trypomastigotes bind to non-
macrophagic cells in a receptor-mediated manner and induce a
bidirectional Ca2+ response, which likely contributes to host-cell
invasion [15]. Recent data indicated that TcSMUG L products,
though not revealed in the T. cruzi proteomic data sets published
so far, constitute a novel mucin-type glycoconjugate restricted to
epimastigote forms [22–26]. In addition to displaying substantial
structural homologies and a common evolutionary origin,
comparative analyses highlighted certain differences between
TcSMUG L and TcSMUG S products [26]. First, TcSMUG L
products, unlike those of TcSMUG S, are not acceptors of sialic
acid residues, likely due to the absence of terminal b-Gal residues
in the proper configuration. Secondly, and at variance with
TcSMUG S products that are expressed at fairly similar levels on
every T. cruzi stock, TcSMUG L expression seems quite variable
among different parasite isolates. Finally, the remarkable conser-
vation of TcSMUG L deduced products within the predicted
mature N-terminal peptide, which does not undergo O-glycosyl-
ation, suggest that they are under positive selection against
diversification [26]. Because of these features, it has been
speculated that structural and/or functional constraints rather
than immunological issues limit TcSMUG diversification.
In the present work, we investigated the role of TcSMUG L
mucins in the attachment of T. cruzi epimastigotes from the
Dm28c stock to the midgut epithelium of R. prolixus and the
consequent development of the protozoan in the insect vector.
Materials and Methods
Insects and Parasites
R. prolixus (Hemiptera: Reduviidae) were obtained from a
longstanding colony reared in the laboratory at 28uC and 60–70%
relative humidity [27] where they were fed on chickens weekly and
raised as previously described [28]. For the in vivo experiments, the
insects were fasted for approximately 15 days and were then fed
with infected heat-inactivated citrated human blood using an
artificial apparatus similar to that described previously [29]. The
T. cruzi Dm28c clone, classified in the TcI phylogenetic group
[30], was maintained in Novy-MacNeal-Nicolle media (NNN) and
brain heart infusion media (BHI- DIFCO) supplemented with
bovine serum albumin (BSA) and hemin. For the in vivo and ex vivo
experiments, epimastigotes were collected during the exponential
growth phase, washed three times in 0.15 M NaCl, 0.01 M
phosphate-buffer, pH 7.2 (PBS) and used immediately [11,31].
Ethics Statement
R. prolixus were fed and raised according to the Ethical
Principles in Animal Experimentation approved by the Ethics
Committee in Animal Experimentation (CEUA/FIOCRUZ)
under the approved protocol number P-54/10-4/LW12/11. The
experiments performed with citrated human blood using an
artificial apparatus were conducted according to the Ethical
Principles in Animal Experimentation approved by the Ethics
Committee in Animal Experimentation (CEUA/FIOCRUZ)
under the approved protocol number L-0061/08. All blood
donors provided informed written consent. Both protocols are
from CONCEA/MCT (http://www.cobea.org.br/), which is
associated with the American Association for Animal Science
(AAAS), the Federation of European Laboratory Animal Science
Associations (FELASA), the International Council for Animal
Science (ICLAS) and the Association for Assessment and
Accreditation of Laboratory Animal Care International (AAA-
LAC).
Mucin Purification
Epimastigotes (109) were delipidated using a water/chloroform/
butan-1-ol treatment and further extracted with butan-1-ol at 4uC
as described previously [32]. Briefly, the soluble fraction was
evaporated under an N2 stream, and the insoluble material was re-
extracted with 66% butan-1-ol in water. The butan-1-ol phase (F1)
contained mainly lipids, phospholipids and glycoinositolpho-
Author Summary
Chagas disease, the major tropical human disease in much
of Latin America, affects approximately 11 million people.
There are 300,000 new cases of Chagas disease and
approximately 21,000 deaths, annually. Triatomine vectors,
including Rhodnius prolixus, are able to transmit the
protozoan Trypanosoma cruzi, the etiological agent of
disease. To develop within insects, the flagellates undergo
morphological changes, modulating surface molecules to
enable interactions with insect tissues such as the
perimicrovilar membranes in the midgut which is an
essential step for their development and successful
transmission to a vertebrate host. The surface of T. cruzi
is covered in glycosyl phosphatidylinositol (GPI)-anchored
mucin molecules that determine parasite protection and
establishment of a persistent infection in vertebrates. A
particular kind of mucin, termed TcSMUG L, is only present
at surface of the insect-dwelling stages of protozoan and,
according to our results, it is involved in the interaction
between T. cruzi and its invertebrate host, determining
both the ex vivo adhesion to the insect midgut cells and
the in vivo development in the vector. Collectively, our
work adds new insight into the relevance of mucin-type
glycoconjugates in the infection of insect vectors and
points to them as promising targets to develop transmis-
sion-blocking strategies for this disease.
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sphates (GIPLs), whereas the aqueous phase (F2) is enriched in
mucins [32]. Both phases were further extracted with 9% butan-1-
ol in water. Delipidated parasite pellets were also extracted with
9% butan-1-ol in water and the mucin-rich aqueous (F3) and
butan-1-ol (F4) phases were stored. The final parasite pellets were
resuspended in denaturing loading buffer containing 6 M urea and
100 mg/ml DNAse I (SIGMA).
Concanavalin A (ConA)-Fractionation and
Phosphatidilinositol-Specific Phospholipase C (PI-PLC)
Treatment
In order to enrich in glycoconjugates, pellets containing 108
parasites were homogenized in ConA buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1% NP40, 0.1% Na deoxycholate, 1 mM
PMSF, 50 mM TLCK, 1 mM DTT) and fractionated in batch
using 200 ml of ConA-sepharose (GE Healthcare) [26]. Elution
was carried out with 300 ml of ConA buffer with 0.5 M a
methylmannoside (Sigma, St. Louis, MO). Parasite total lysates
were treated with PI-PLC and submitted to Triton X-114 partition
as described [26], to ascertain the presence of GPI anchor.
Gel Electrophoresis and Western Blots
Gel electrophoresis was performed under denaturing conditions
in 15% SDS-PAGE. For Western blots using total proteins, lysates
corresponding to ,107 parasites prepared as described [26] were
loaded in each lane, transferred to PVDF membranes (GE
Healthcare), reacted with the appropriate antiserum followed by
HRP-conjugated secondary Abs (Sigma) and developed using
chemiluminescence (Pierce). Antibodies to TcSMUG L were
affinity-purified and used as described by [26]. Rabbit antiserum
to glutamate dehydrogenase from T. cruzi (TcGDH) was used at
1:3,000 dilution [33].
Peptides
Peptides used in this study were synthesized bearing an acetyl
group on their N-termini and a C-terminal Cys residue (Gen-
Script). Sequences were derived from the predicted N-terminal
region of mature TcSMUG L (AVFKAAGGDPKKNTTC),
TcSMUG S (VEAGEGQDQTC) and TSSA (TPPSGTENKPAT-
GEAPSQPGAC) products. When indicated, peptides were syn-
thesized with a biotin group instead of the acetyl group on their N-
termini. Although bioinformatics methods indicate that the
sequences EEGQYDAAVFAVFKAAGGDPKKNTT and EEG-
QYDAAVFVEAGEGQDQT constitute the predicted mature N-
termini for TcSMUG L and S products, respectively [26], mass
spectrometry-based data using purified epimastigote total mucins
[34], strongly suggested a further trimming of the EEGQY-
DAAVF sequence in vivo.
Ex Vivo Interaction between R. prolixus Posterior Midgut
Cells and T. cruzi Epimastigotes
After washing in PBS, epimastigotes were suspended in fresh
BHI to a density of 2.56107 cells/ml. Samples of an interaction
medium composed of 200 ml of this parasite suspension together
with posterior midguts, freshly dissected and washed only in PBS,
from insects collected 10 days after a non-infectious blood meal,
were placed in Eppendorf microtubes [10] and incubated for
30 min at 25uC (non-treated control group). Under these
conditions, epimastigotes adhered to the luminal surface of midgut
epithelium cells [11]. For the experimental groups, the midguts
were previously incubated (30 min, 25uC) in PBS supplemented
with TcSMUG S (negative control), TcSMUG L or TSSA
peptides at different concentrations. The treated-posterior midguts
were then washed in fresh PBS and immediately added to the BHI
interaction medium containing parasites. After incubation
(30 min, 25uC), all midgut preparations were spread onto glass
slides to count the number of attached parasites. A Zeiss
microscope with reticulated ocular, equipped with a video
microscopy camera, was used for counting parasites attached to
100 randomly chosen epithelial cells in 10 different fields of each
midgut preparation. For each experimental group, 10 insect
midguts were used [35,36].
In Vivo Infection Assays
Fifth-instar nymphs of regularly fed R. prolixus, which had been
starved for 7 days after the last ecdysis, were fed on artificial
bloodmeal apparatus with a mixture of heat-inactivated citrated
human blood and epimastigotes (26105 parasites/ml) as previ-
ously described [37]. TcSMUG S (negative control), TSSA or
TcSMUG L peptide was added to the infected blood meal to a
final concentration of 30 mg/ml just before feeding. At days 7, 14
or 21, the entire digestive tracts consisting of anterior midgut
(stomach), posterior midgut and rectum of 10 insects were
dissected and homogenized in a small volume of PBS. Afterwards,
additional PBS was added to fill the homogenates to 1 ml [38,39].
The number of parasites in each homogenate was determined
using a Neubauer hemocytometer [40,41]. Each experiment was
repeated at least three times.
Light Microscopy
Posterior midgut compartments obtained by dissection were
fixed for 2 h at room temperature in 2.5% glutaraldehyde diluted
in 0.1 M cacodylate buffer, pH 7.2, and washed twice in the same
buffer. Post-fixation was performed in the dark for 2 h in 1%
osmium tetroxide diluted in 0.1 M cacodylate buffer, pH 7.2,
followed by dehydration with continuous acetone series (70%,
90% and 100%, respectively). Samples were then embedded in
epoxy resin and polymerized at 60uC for three days. Thick plastic
sections were stained with toluidine blue and observed under an
Axioplan MC 100 spot microscope [10].
Fluorescence Microscopy and Histochemical Studies
Dissected posterior midgut fragments were fixed for 1 h at
room temperature in 4% p-formaldehyde diluted in 0.1 M
cacodylate buffer, pH 7.2. Afterwards, samples were washed
in PBS containing 1% of BSA, pH 7.2 (PBS-BSA) and
incubated for 30 min in 50 mM ammonium chloride solution
followed by another washing step in PBS-BSA at room
temperature. Tissues were then incubated with biotin-labeled
TcSMUG S, TSSA or TcSMUG L peptide diluted in PBS-
BSA for 1 h at room temperature and washed again in PBS-
BSA before incubation with FITC-labeled-Avidin conjugate
(SIGMA) (1:100) for 1 h and washed in distilled water in the
dark for 10 min [42]. For the control groups, the incubation
with biotin-labeled peptides was omitted. Finally, the tissues
were spread onto glass slides for visualization using an
emission filter of 488 nm and observed under an Axioplan
MC 100 spot microscope coupled to an Axiovision system
computer [43].
Data Analysis
Results were analyzed using ANOVA and Tukey’s tests [44]
using Stats Direct Statistical Software, version 2.2.7 (StatsDirect
Ltd., Sale, Cheshire, UK). Differences between treated- and
control-groups were considered non-statistically significant when
p.0.05. Probability values are specified in the text.
TcSMUG L Mucins on T. cruzi Development in Vector
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Results
TcSMUG L Products Are Expressed as Mucin-Like
Molecules in Dm28c Epimastigotes
Previous results indicate that the expression level of TcSMUG L-
encoded products is quite variable among epimastigotes from
different T. cruzi isolates [26]. Therefore, as a first step toward
the validation of our R. prolixus infection model, we undertook
preliminary characterization of TcSMUG L products in the
DM28c stock. Western blotting assays carried out over total
epimastigote lysates and probed with affinity-purified antibodies
directed against an N-terminus-derived TcSMUG L peptide
revealed a major ,35 kDa band, thus in the range of fully
processed TcSMUG L products described in other parasite stocks
[26] (Fig. 1A). As controls, we used analogous fractions from
epimastigotes from Adriana and CL Brener stocks, which
showed the greatest differences in terms of TcSMUG L
expression [26]. The results were normalized by re-probing
the membrane with antiserum directed against TcGDH.
Densitometric analyses indicated that TcSMUG L expression
levels from the DM28c stock were roughly equivalent (86%) to
that of CL Brener. These products were removed from the
parasite surface following PI-PLC treatment [26], a molecular
signature of GPI-anchored molecules (not shown), and were
specifically retained following ConA chromatography (Fig. 1B),
indicating they bear terminal a-D-mannosyl and/or a-D-
glucosyl residues, as described for other stocks [26]. To analyze
whether TcSMUG L products behaved as mucin-type proteins,
i.e., underwent extensive O-glycosylation, we purified total
mucins from Dm28c epimastigotes following a standard
butan-1-ol extraction protocol [32] and probed these fractions
by Western blot. As shown in Fig. 1C, TcSMUG L products were
mostly detected in the F3 fraction, which was highly enriched in
gp35/50, as verified by mAb 2B10 and 10D8 reactivity (not
shown). The presence of high-molecular weight aggregates in
purified TcSMUG L products has been described for other T.
cruzi mucin-type glycoconjugates [22,26]. A minor fraction was
also revealed in the pellet, which might be ascribed to
incomplete extraction. Together, these results strongly suggest
that Dm28c epimastigotes express high levels of fully processed
TcSMUG L product on their surface.
TcSMUG L Products Are Involved in Epimastigote Ex Vivo
Attachment to R. prolixus Posterior Midgut Epithelium
To assess whether TcSMUG L products can act as direct
ligands for possible receptors in insect epithelial midgut cells,
we tested the effect of pre-treatment of dissected midguts with
a peptide spanning the TcSMUG L mature N-terminus. As
controls, we assayed in parallel the effect of the corresponding
peptide derived from TcSMUG S and TSSA, a member of the
TcMUC family of mucins. As a first set of experiments, in
posterior R. prolixus midgut preparations obtained from a
control (non-treated) group, 114.8628.2 epimastigotes were
found attached per 100 midgut cells (Fig. 2A). Similar adhesion
rates (128.8634.7/100 midgut cells) were obtained when
midguts were first incubated with 1 mg/ml of a control
TcSMUG S peptide (p.0?05) (Fig. 2A). In contrast, attach-
ment of only 28.5628.4 and 20.8610.06 epimastigotes per 100
cells of the midgut epithelium were recorded when the
flagellates were pre-incubated with 1 mg/ml of either TcSMUG
L or a control TcMUC-derived (TSSA) peptide (p,0?0001),
respectively (Fig. 2A). A dose-dependent effect on the ex vivo
attachment of epimastigotes was verified for the latter
molecules, indicating that the presence of either synthetic
peptide blocked a potential ligand-receptor interaction involved
in epimastigote attachment (Fig. 2B). As shown in Fig. 2B,
incubation with 0.01 mg/ml of the TcSMUG L peptide did not
affect flagellate adhesion rates when compared with the control
group, whereas incubation with 0.1 mg/ml or 1 mg/ml of the
TcSMUG L peptide reduced T. cruzi attachment to 40.8
616.78 and 30.8 610.42 (p,0?01) epimastigotes per 100
midgut cells, respectively. Similarly, midgut incubation with
0.01 mg/ml of the TSSA peptide resulted in 128.6620.87epi-
mastigotes attached per 100 midgut cells and did not affect
flagellate adhesion rates when compared with the control
group (123.2623.74 epimastigotes/100 midgut cells), whereas
incubation with 0.1 mg/ml or 1 mg/ml of the same peptide
reduced T. cruzi attachment to 37.6 619.65 and 30.6 612.4
(p,0?001) epimastigotes per 100 midgut cells, respectively
(Fig. 2C). Therefore, our results showed that the pre-incubation
of R. prolixus midguts with the TcSMUG L or TSSA peptide
promote significant alteration of the epimastigote-midgut
interaction rate.
Figure 1. Western blots of TcSMUG L products from T. cruzi. A) Extracts of epimastigotes from different parasite stocks (Ad, Adriana; CL, CL
Brener; Dm, Dm28c) were probed with either anti-TcSMUG L antibodies or anti-glutamate dehydrogenase (GDH) antiserum. B) ConA-fractionated
extracts of Dm28c epimastigotes were probed with anti-TcSMUG L antiserum. ft, flow-through. C) Butan-1-ol extraction analysis of Dm28c delipidated
epimastigotes. Fractions, named according to [19], were probed with affinity-purified anti-TcSMUG L antibodies. Molecular mass markers (in kDa) are
indicated at right. *Denotes aggregates.
doi:10.1371/journal.pntd.0002552.g001
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TcSMUG L Products Are Involved in T. cruzi In Vivo
Development in the Insect Vector
Upon ingestion of approximately 26105 Dm28c epimastigotes/
ml of blood, fifth-instar nymphs of R. prolixus became heavily infected
with T. cruzi (Fig. 3). In the control group, the infection levels varied
from 3.3360.356105 flagellates/ml of digestive tract homogenate 7
days after infection to 2.0660.106106 flagellates/ml of digestive
tract 21 days post-infection. Similar infection levels were observed
throughout the time frame of the experiment in insect groups fed
with blood supplemented with either TcSMUG S or TSSA peptide
(p.0?05). In contrast, nymphs fed with blood supplemented with
TcSMUG L peptide showed significantly reduced infection levels.
Direct counts revealed 2.360.126102 (p,0?0001) and
2.360.276102 (p,0?0001) flagellates/ml of digestive tract homog-
enate 14 and 21 days post-infection, respectively, representing a,4-
log difference from controls. Even more compelling, no parasites
were observed 7 days post-infection in TcSMUG L peptide-treated
insects. Together, these results suggest that soluble TcSMUG L
peptide significantly inhibits the normal development of Dm28c
parasites in R. prolixus, likely by interfering between the interaction of
endogenous TcSMUG L products displayed on the surface of
epimastigotes and triatomid midgut receptors.
Light Microscopy and Histochemical Localization of
TcSMUG L Recognition Sites in the Posterior Midgut of R.
prolixus
Light microscopy of R. prolixus midgut showed a single columnar
epithelium composed by posterior midgut cells. Toluidine-stained
granules were observed in the apical and medial region, where a
round nucleus was located. As previously described [10], these
epithelial cells were closely joined at their medial and basal
regions, whereas a brush border associated with the PMM was
observed at the luminal surface of their apical regions (Fig. S1). No
significant labeling was obtained after incubation of R. prolixus
posterior midgut surface with Avidin-FITC conjugate alone
(Fig. 4A, B) or after previous incubation with biotin-labeled
TcSMUG S peptide followed by the Avidin-FITC conjugate
(Fig. 4E, F). However, in line with previous results, fluorescence of
specific binding sites was observed on the surface of luminal
posterior midgut cells after pre-incubation with biotin-labeled
TcSMUG L (Fig. 4C, D) or TSSA (Fig. 4G, H) peptide under the
same conditions. Unexpectedly, the samples pre-incubated with
TSSA also showed some intracellular staining, particularly in the
nucleolus, which may be attributed to partial permeabilization of
the cells during fixation.
Figure 2. Effect of surface mucins on ex vivo T. cruzi attachment to the midgut epithelium of Rhodnius prolixus. Midguts obtained from
male fifth-instar nymphs 10 days after the bloodmeal were previously incubated for 30 min in PBS supplemented with the indicated mucin peptides
and added with BHI interaction medium containing flagellates (2.56107/ml). Pre-incubation with mucin peptides was omitted in control (non-treated)
group. Adhered epimastigotes were counted per 100 epithelial cells in 10 different fields of each midgut preparation. (A) Pre-incubation in 1 mg/ml of
TcSMUG S, TSSA or TcSMUG L. (B) Pre-incubation in 0.01, 0.1 or 1.0 mg/ml of TcSMUG L. (C) Pre-incubation in 0.01, 0.1 or 1.0 mg/ml of TSSA. Each
group represents mean 6 S.D. of parasites attached in 10 midguts. Asterisk represents experimental groups with statistical significance compared to
the control. Trypanosoma cruzi small mucin S (TcSMUG S), Trypanosoma cruzi small mucin L (TcSMUG L) and trypomastigote small surface antigen
(TSSA).
doi:10.1371/journal.pntd.0002552.g002
Figure 3. Effect of surface mucins on T. cruzi in vivo development in the digestive tract of Rhodnius prolixus. Insects were fed on citrated,
complement-inactivated human blood containing 26105 flagellates/ml. Each mucin peptide was added to the bloodmeal at a concentration of
30 mg/ml and insects dissected as days 7, 14 or 21 post feeding. Each point represents mean6S.D of flagellates/ml in the whole gut of 10 insects.
Asterisk represents experimental groups with statistical significance compared to the control.
doi:10.1371/journal.pntd.0002552.g003
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Figure 4. Photomicrographs of posterior midgut epithelial cells of fifth-instar R. prolixus incubated with biotin-labeled peptides. (A)
Light microscopy showing single-globe columnar epithelial cells(white star) and PMM (white arrow). (B) Fluorescence microscopy showing that no
demarcation was observed after incubation with avidin-FITC-labeled conjugate alone. Light and fluorescence microscopy, respectively, of samples
incubated with biotin-labeled TcSMUG L (C and D), biotin-labeled TcSMUG S (E and F), and biotin-labeled TSSA (G and H). Fluorescence of the surface
and nucleolus of the midgut cells is indicated by white and black arrows (respectively). 4006.
doi:10.1371/journal.pntd.0002552.g004
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Discussion
During its life cycle, T. cruzi adheres to specific host molecules/
cell types as essential steps for parasite survival. Depending on the
parasite developmental stage and the nature of the involved
molecules, these interactions trigger a variety of events such as
bidirectional cell signaling, host cell internalization, parasite
replication or transformation to infective stages [45,46]. Within
the triatomid vector, different lines of research have established
that molecules able to inhibit parasite attachment to insect tissues
ex vivo also often efficiently block the in vivo development of T. cruzi
[35]. For instance, purified GIPLs were shown to bind to the
luminal surface of the posterior midgut. Accordingly, their
exogenous addition dramatically impaired both ex vivo attachment
of epimastigotes to this organ and the flagellate multiplication in
the insect digestive tract, which prevented the successful coloni-
zation of the vector [11]. Similar effects were described for
different carbohydrate-binding proteins (CBPs) of the epimastigote
surface with a strong affinity for higher glycan oligomers and
sulfated glycosaminoglycans (S-GAGs) present in the posterior
midgut of R. prolixus [36,47,48]. The net negative charge of both S-
GAGs and specific carbohydrates may act as a first, non-specific
step prior to T. cruzi adhesion to specific receptors in the luminal
midgut PMM [35]. In addition, an antiserum raised against R.
prolixus PMM and midgut tissue interfered with midgut structural
organization and slowed the development of T. cruzi in the insect
vector [49].
The entire surface, including the cell body and the flagellum, of
various T. cruzi developmental forms is covered with mucins that
play a key role in parasite protection [50–52], infectivity, and
development [15]. T. cruzi mucins are anchored to the outer leaflet
of the plasma membrane through a GPI motif and undergo
extensive glycosylation in their central Thr-rich domain. These
features confer strong hydrophilic characteristics and an extended
(‘‘rod-like’’) structural conformation [53], which is often used to
elevate an outermost peptide above the parasite glycocalix. This
N-terminal peptide, which is not predicted to be O-glycosylated, is
thus ideally suited to participate in cell-to-cell interaction
phenomena [54].
The results presented here strongly suggest that the N-
terminal peptide of TcSMUG L products is required for efficient
interaction between the parasite and the insect midgut and the
subsequent growth of the flagellate in the invertebrate host. As
shown, addition of the exogenous peptide led to a significant
reduction in ex vivo adhesion to the insect midgut, and also
inhibition of in vivo development within vectors. Due to its small
molecular size, this effect is unlikely to be caused by steric
effects, where the TcSMUG L peptide would prevent access of
parasite recognition molecules to specific sites in the insect gut
cells. Quite the opposite, we favor the hypothesis that the
exogenous TcSMUG L peptide exerts its inhibitory effect by
outcompeting the parasite binding sites in the triatomine
luminal surface of the midgut epithelium. This idea is further
supported by histochemical data showing intense labeling of the
surface of luminal posterior midgut cells after pre-incubation
with biotin-labeled TcSMUG L peptide. Therefore, it is likely
that TcSMUG L products act as surface adhesion molecules,
promoting epimastigote adhesion and colonization through recog-
nition of specific receptor(s) on insect cells. In this framework, a
distinct expression profile verified for TcSMUG L products [26]
could contribute to the biological heterogeneity found between
different isolates of T. cruzi in terms of triatomid infectivity.
Moreover, drastic reduction in TcSMUG L expression upon
differentiation to metacyclic trypomastigotes suggests a develop-
mental regulation program that could help to explain why these
latter forms are detached from the midgut surface [26].
One unexpected and puzzling finding was that the exogenous
TSSA-derived peptide showed adhesion properties to insect
midgut cells, as well as ex vivo inhibition on epimastigote
attachment. It is worth mentioning that TSSA belongs to the
TcMUC group of genes, which is expressed during the mamma-
lian-dwelling stages of the protozoan [20,21,54]. In particular,
TSSA expression is restricted to the surface of blood trypomasti-
gotes, the parasite stage ingested by the vector during an infective
blood meal, and amastigote-to-bloodstream trypomastigote inter-
mediate forms. From a structural staindpoint, and despite showing
similar bias in amino acid composition (with Cys, Phe, Trp and
Tyr amino acids -all residues that could perturb the physico-
chemical properties of T. cruzi mucins- being underrepresented or
absent), there are no obvious similarities in the primary sequences
of the TSSA and TcSMUG L peptides that could explain their
similar binding properties. Indeed, the labeling pattern obtained
for TSSA in posterior midgut sections is different than that
obtained for the TcSMUG L peptide, suggesting they recognize
different receptor(s) on the surface of insect cells, although more
studies would be required to address this point. Importantly, and
in strict correlation with its expression profiling, the interaction
between TSSA and insect midgut cells seems to have no biological
relevance, as it had no effect on parasite in vivo development.
Although little is known about the mechanisms leading to the
remodeling of the surface coat when the flagellate moves from the
mammal into the insect vector, it is reasonable to suppose that
TSSA is shed during this process. Free in the insect stomach,
TSSA may reach the posterior midgut and be recognized by PMM
receptors for mucins or other glycoconjugates. Transfer of
antigenic epitopes from T. cruzi to the PMM of Triatoma infestans
has been previously described [55]. In spite of this, TSSA does not
seem to participate in the protozoan development of R. prolixus,
which is compatible with its lack of expression in insect-dwelling
stages of T. cruzi.
Altogether, these findings establish that TcSMUG L products are
involved in the interaction between T. cruzi and its invertebrate
host. Indeed, our results demonstrate that these products are
involved in successful adhesion to the epithelial cells of insect
vectors both ex vivo and in vivo, although the exact molecular
mechanism, and particularly the putative receptor on the surface
of the insect cells, should be further explored. Most importantly, a
severe reduction in flagellate population in the digestive tract of R.
prolixus was observed when triatomines were infected with
epimastigotes of T. cruzi and simultaneously orally treated with
the TcSMUG L peptide. Collectively, our work adds new insight
into the relevance of mucin-type glycoconjugates in the infection
of insect vectors and points to them as promising targets to develop
transmission-blocking strategies for this disease.
Supporting Information
Figure S1 Light microscopy of toluidin blue-stained
posterior midgut cells of R. prolixus 10 days after
feeding. Oblique (a) and transverse (b) sections of the apical
region of columnar epithelial cells, with brush border associated
with perimicrovillar membranes (thick black arrow), round nuclei
(thin black arrow) and the posterior midgut lumen (L). 4006.
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